ArticlePharmaceutics2018

Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment.

Silvia Tampucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.